ArticleThoracic cancer2019

Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non-small cell lung cancer patients.

Ayako Shiono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.